Literature DB >> 34342986

Quantitative NMR Study of Insulin-Degrading Enzyme Using Amyloid-β and HIV-1 p6 Elucidates Its Chaperone Activity.

Bhargavi Ramaraju1, Spencer L Nelson1, Wenwei Zheng2, Rodolfo Ghirlando3, Lalit Deshmukh1.   

Abstract

Insulin-degrading enzyme (IDE) hydrolyzes monomeric polypeptides, including amyloid-β (Aβ) and HIV-1 p6. It also acts as a nonproteolytic chaperone to prevent Aβ polymerization. Here we compare interactions of Aβ and non-amyloidogenic p6 with IDE. Although both exhibited similar proteolysis rates, the binding kinetics to an inactive IDE characterized using relaxation-based NMR were remarkably different. IDE and Aβ formed a sparsely populated complex with a lifetime of milliseconds in which a short hydrophobic cleavage segment of Aβ was anchored to IDE. Strikingly, a second and more stable complex was significantly populated with a subsecond lifetime owing to multiple intermolecular contacts between Aβ and IDE. By selectively sequestering Aβ in this nonproductive complex, IDE likely increases the critical concentration required for fibrillization. In contrast, IDE and p6 formed a transient, submillisecond complex involving a single anchoring p6 motif. Modulation of intermolecular interactions, thus, allows IDE to differentiate between non-amyloidogenic and amyloidogenic substrates.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34342986      PMCID: PMC8895387          DOI: 10.1021/acs.biochem.1c00342

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  20 in total

1.  Reconstructing NMR spectra of "invisible" excited protein states using HSQC and HMQC experiments.

Authors:  Nikolai R Skrynnikov; Frederick W Dahlquist; Lewis E Kay
Journal:  J Am Chem Soc       Date:  2002-10-16       Impact factor: 15.419

Review 2.  Multiple functions of insulin-degrading enzyme: a metabolic crosslight?

Authors:  Grazia R Tundo; Diego Sbardella; Chiara Ciaccio; Giuseppe Grasso; Magda Gioia; Andrea Coletta; Fabio Polticelli; Donato Di Pierro; Danilo Milardi; Peter Van Endert; Stefano Marini; Massimo Coletta
Journal:  Crit Rev Biochem Mol Biol       Date:  2017-06-21       Impact factor: 8.250

3.  Probing the transient dark state of substrate binding to GroEL by relaxation-based solution NMR.

Authors:  David S Libich; Nicolas L Fawzi; Jinfa Ying; G Marius Clore
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-24       Impact factor: 11.205

Review 4.  Chemical exchange in biomacromolecules: past, present, and future.

Authors:  Arthur G Palmer
Journal:  J Magn Reson       Date:  2014-04       Impact factor: 2.229

Review 5.  The irreversible binding of amyloid peptide substrates to insulin-degrading enzyme: a biological perspective.

Authors:  Matías B de Tullio; Laura Morelli; Eduardo M Castaño
Journal:  Prion       Date:  2008-05-01       Impact factor: 3.931

Review 6.  Amyloid-beta precursor protein processing in neurodegeneration.

Authors:  Valérie Wilquet; Bart De Strooper
Journal:  Curr Opin Neurobiol       Date:  2004-10       Impact factor: 6.627

7.  Conformational states and recognition of amyloidogenic peptides of human insulin-degrading enzyme.

Authors:  Lauren A McCord; Wenguang G Liang; Evan Dowdell; Vasilios Kalas; Robert J Hoey; Akiko Koide; Shohei Koide; Wei-Jen Tang
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-06       Impact factor: 11.205

8.  Insulin-degrading enzyme (IDE): a novel heat shock-like protein.

Authors:  Grazia Raffaella Tundo; Diego Sbardella; Chiara Ciaccio; Antonio Bianculli; Augusto Orlandi; Maria Giovanna Desimio; Gaetano Arcuri; Massimiliano Coletta; Stefano Marini
Journal:  J Biol Chem       Date:  2012-11-27       Impact factor: 5.157

9.  Clinical and biomarker changes in dominantly inherited Alzheimer's disease.

Authors:  Randall J Bateman; Chengjie Xiong; Tammie L S Benzinger; Anne M Fagan; Alison Goate; Nick C Fox; Daniel S Marcus; Nigel J Cairns; Xianyun Xie; Tyler M Blazey; David M Holtzman; Anna Santacruz; Virginia Buckles; Angela Oliver; Krista Moulder; Paul S Aisen; Bernardino Ghetti; William E Klunk; Eric McDade; Ralph N Martins; Colin L Masters; Richard Mayeux; John M Ringman; Martin N Rossor; Peter R Schofield; Reisa A Sperling; Stephen Salloway; John C Morris
Journal:  N Engl J Med       Date:  2012-07-11       Impact factor: 91.245

10.  Proteolytically inactive insulin-degrading enzyme inhibits amyloid formation yielding non-neurotoxic aβ peptide aggregates.

Authors:  Matias B de Tullio; Valeria Castelletto; Ian W Hamley; Pamela V Martino Adami; Laura Morelli; Eduardo M Castaño
Journal:  PLoS One       Date:  2013-04-11       Impact factor: 3.240

View more
  2 in total

Review 1.  Insulin-Degrading Enzyme, an Under-Estimated Potential Target to Treat Cancer?

Authors:  Laetitia Lesire; Florence Leroux; Rebecca Deprez-Poulain; Benoit Deprez
Journal:  Cells       Date:  2022-04-05       Impact factor: 6.600

2.  Exchange Broadening Underlies the Enhancement of IDE-Dependent Degradation of Insulin by Anionic Membranes.

Authors:  Qiuchen Zheng; Bethany Lee; Micheal T Kebede; Valerie A Ivancic; Merc M Kemeh; Henrique Lemos Brito; Donald E Spratt; Noel D Lazo
Journal:  ACS Omega       Date:  2022-07-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.